The SMART strategy: Subdividing M1 stage and aiming remission for target nasopharyngeal carcinoma patients with metachronous metastasis.

被引：0
|
作者：
Shen, Lujun [1 ]
Wu, Peihong [1 ]
Xia, Yunfei [1 ]
Li, Wang [1 ]
Chen, Chen [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.6034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6034
引用
收藏
页数：1
相关论文
共 22 条
  • [21] ASO Author Reflections: Multimodal Treatment, Including Surgery, for Patients with Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma Showed Promising Prognosis
    Igaue, Shota
    Daiko, Hiroyuki
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (02) : 897 - 898
  • [22] Risk of Recurrence and Metastasis for Patients with T1N0M0 Esophageal Carcinoma Who Achieve Completed Resection via Endoscopic Submucosal Resection: Evidence for the Appropriateness of the Watch and Wait Follow-Up Strategy
    Zhu, Li-Hua
    Yao, Jun
    Wu, Ting
    Wang, Yan
    Wang, Chen-Wei
    Xue, Chun-Quan
    Wu, Li-Guang
    Fan, Xing-Wen
    Wu, Chao-Yang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2427 - 2435
123